| Name | Title | Contact Details |
|---|
Founded by two scientists with a deep love for animals, SenesTech is a biotech platform and research company that has developed an innovative technology for managing animal populations by fertility control. We develop non-lethal treatments that have the potential to be more effective, more humane, and less invasive to the environment than traditional management methods. SenesTech’s first product applies our revolutionary technology to a worldwide problem that has persisted since the Middle Ages: the proliferation of rats in both urban and agricultural settings. Our innovative compound is readily consumed by rats and leaves them non-reproductive with no other observable side effects. The rodents live out their normal 8-12 month life span without producing offspring. Since rapid reproduction is the root cause of rat infestation, this introduces a new paradigm to the science of pest control. When used as directed, our species-specific formulation is environmentally neutral, does not affect non-target animals, and has no impact on human health or fertility.
Nacalai USA is a San Diego, CA-based company in the Healthcare, Pharmaceuticals, and Biotech sector.
Developing Transformative Gene-based Medicines for Patients with Serious Diseases The mission of CRISPR Therapeutics is to develop transformative gene-based medicines for patients with serious diseases. Our therapeutic approach is to cure diseases at the molecular level using the breakthrough gene editing technology called CRISPR-Cas9.
HealthScape is a Tampa, FL-based company in the Healthcare, Pharmaceuticals, and Biotech sector.
Centre for Commercialization of Regenerative Medicine , a Canadian not-for-profit organization funded by the Government of Canada`s Networks of Centres of Excellence program, the Province of Ontario, and leading academic and industry partners, supports the development of regenerative medicines and associated enabling technologies, with a specific focus on cell and gene therapy. CCRM aims to accelerate the translation of scientific discovery into marketable products for patients with specialized teams funding, and infrastructure. CCRM sources and evaluates intellectual property from around the globe, offers various consulting services, conducts development projects with partners, and establishes new companies built around strategic bundles of intellectual property. CCRM is the commercialization partner of the Ontario Institute for Regenerative Medicine and the University of Toronto`s Medicine by Design. CCRM is hosted by the University of Toronto and was launched in Toronto`s Discovery District on June 14, 2011.